Electronic publication
All publications

Fresh number Т. 14, №2 (54)
  • Original Articles
    • The effect of free and liposomal doxorubicin on the morphofunctional characteristics of saos-2 osteosarcoma cells under the influence of induction moderate hyperthermia
    Authors: Orel V.Е. Diedkov A.G. Ostafiichuk V.V. Kolesnyk D.L.... Т. 14, №2 (54)
    The role of the tumor microenvironment in predicting the survival of patients with stage I–III colon adenocarcinoma
    Author:Shkurupii B.M. Т. 14, №2 (54)
    Assessment of the toxicity profile and safety of integrating metformin into neoadjuvant chemotherapy for breast cancer
    Authors: Avierin D. Zavizion V. Т. 14, №2 (54)
    Results of treatment of patients with stage I uterine sarcoma
    Authors: Davydiuk S.S. Kryzhanivska A.Y. Т. 14, №2 (54)
    Evaluation of quality of life after modified pectoralis major myocutaneous flap reconstruction to repair postoperative defects in patients treated for mouth and tongue cancer
    Authors: Chernienko V.V. Kravets O.V. Burtyn O.V. Kopchak A.V.... Т. 14, №2 (54)
  • Review Articles
    • An updated systematic review, meta-analysis and network meta-analysis of the clinical benefit and safety of gemtuzumab ozogamicin in treating acute myeloid leukemia in various subgroups
    Т. 14, №2 (54)
    Relationship of special molecular mechanisms in colorectal cancer. Literature review
    Authors: Pokitko O.V. Sulayeva O.M. Mashukov A.O. Merlich S.V.... Т. 14, №2 (54)
    Intra-arterial chemotherapy in locally advanced cervical cancer: a review of the scientific literature
    Authors: Cherchenko K. Lukashenko A. Patsko V. Kostikov V.... Т. 14, №2 (54)
    The role of intra-abdominal pressurized aerosol chemotherapy (pipac) in the treatment of gastric cancer peritoneal carcinomatosis: a systematic review
    Authors: Pepenin M. Kondratskyi Y. Horodetskyi A. Dobrzhanskyi O. Т. 14, №2 (54)
  • Topical
    • The era of «targets» in the treatment strategy of resectable NSCLC: from ADAURA to NeoADAURA…
    Т. 14, №2 (54)
    New opportunities in first-line therapy of unresectable EGFRm NSCLC. Overview of clinical trials FLAURA, FLAURA2, LAURA
    Т. 14, №2 (54)
    Whole number